As the page turned on 2025, optimism was high among life sciences dealmakers. Elections in the U.S. and other major economies had concluded, interest rates were poised to come in to focus, and the regulatory environment...more
8/27/2025
/ Acquisition Agreements ,
Biotechnology ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Foreign Investment ,
Global Dealmaking ,
Healthcare ,
Investment ,
Life Sciences ,
Merger Agreements ,
National Security ,
Pharmaceutical Industry ,
Prescription Drugs
Cautious Optimism for Deal Making. The general consensus is that we will likely see an increase in M&A and capital market transactions in the life sciences sector in 2025....more
1/22/2025
/ Acquisition Agreements ,
Artificial Intelligence ,
Biotechnology ,
Capital Markets ,
Data Protection ,
Healthcare ,
Investment ,
Life Sciences ,
Merger Agreements ,
Pharmaceutical Industry ,
Regulatory Agenda ,
Telehealth
The Licensing Executives Society (LES) recently held its annual meeting in New Orleans, drawing together a diverse group of intellectual property (IP) licensing professionals, including attorneys, academics, service...more
ARTIFICIAL INTELLIGENCE IN LIFE SCIENCES -
Life sciences companies are forming AI-driven strategic collaborations with tech giants, creating synergy that promises to revolutionize the industry. Companies like NVIDIA,...more
8/20/2024
/ Algorithms ,
America Invents Act ,
Artificial Intelligence ,
Bayh-Dole Act ,
Chevron Deference ,
Healthcare ,
Inflation Reduction Act (IRA) ,
Innovative Technology ,
Intellectual Property Protection ,
Life Sciences ,
Machine Learning ,
March-in Rights ,
NIST ,
Non-Compete Agreements ,
Patents ,
Post-Grant Review ,
Prior Art ,
USPTO
Ballard Spahr attorneys from the firm’s Life Sciences and Health Care Industry Teams were on the ground for the 42nd Annual J.P. Morgan Healthcare Conference (JPM24) from January 7-10. While still less crowded than...more
1/22/2024
/ Acquisitions ,
Antitrust Provisions ,
Coronavirus/COVID-19 ,
Department of Justice (DOJ) ,
Drug Pricing ,
Federal Trade Commission (FTC) ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Initial Public Offering (IPO) ,
Life Sciences ,
Medicare ,
Mergers ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Private Equity
The Inflation Reduction Act (IRA), signed into law in August 2022, impacted a wide range of tax laws and touched many aspects of government. Significantly, part of the IRA provides Medicare with the ability to negotiate the...more
7/21/2023
/ Artificial Intelligence ,
Benchmarking ,
Coronavirus/COVID-19 ,
Data Privacy ,
Data Protection ,
Department of Justice (DOJ) ,
Drug Pricing ,
Federal Trade Commission (FTC) ,
Inflation Reduction Act (IRA) ,
Intellectual Property Protection ,
Life Sciences ,
Non-Compete Agreements ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry
Summary -
The 41st Annual JP Morgan Healthcare Conference in rainy San Francisco earlier this month was relatively low-key compared to pre-pandemic versions of the health care investment symposium, which returned this year...more